Enzinger FM, Weiss SW, editors
Some doctors also worry that a surge in demand could strain busy clinics and pharmacies, while others pointed to a lack of broader public awareness about the program
Clinically, the ATTAIN Phase 3 program showed that orforglipron at its highest dose delivered a mean weight loss of 12.4% over 72 weeks, slightly less than the WEGOVY pills 13.6% at 64 weeks, but with a broader, more diverse patient population of over 3,000 participants
Obesity is a chronic disease that requires long-term management, much like high blood pressure or high cholesterol.") With the medication imitating GLP-1a hormone that naturally occurs in the body, to lower blood sugar levelsit manages appetite by affecting both the stomach and brain
[DOI] [PubMed] [Google Scholar] 99.Baggio LL, Drucker DJ